Article info

Download PDFPDF
Parkin and PINK1 mutations in early-onset Parkinson’s disease: comprehensive screening in publicly available cases and control
  1. Dr S W Scholz, Laboratory of Neurogenetics, National Institute on Aging, 35 Convent Drive, 20892 Bethesda, MD, USA; scholzs{at}mail.nih.gov
View Full Text

Citation

Brooks J, Ding J, Simon-Sanchez J, et al
Parkin and PINK1 mutations in early-onset Parkinson’s disease: comprehensive screening in publicly available cases and control

Publication history

  • Received October 16, 2008
  • Revised January 1, 2009
  • Accepted January 27, 2009
  • First published April 6, 2009.
Online issue publication 
June 01, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.